NCT03725397

Brief Summary

To compare the efficacy and safety of cervical ripening with transcervical Foley catheter in inpatient vs outpatient setting

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2018

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 31, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

January 8, 2019

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 27, 2022

Completed
Last Updated

February 22, 2023

Status Verified

February 1, 2023

Enrollment Period

3.5 years

First QC Date

June 22, 2018

Last Update Submit

February 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time of Foley catheter extrusion

    Antepartum time of Foley catheter extrusion before patient being brought to labor

    within 24 hours

Secondary Outcomes (11)

  • Bishop score

    during labor

  • Total time in cervical ripening

    from labor induction to delivery time

  • Total time slept during pre-induction

    during labor

  • Total time in hospital

    no max but an average of 3 days

  • Analgesia used during pre-induction

    within 24 hours before Pitocin initiation

  • +6 more secondary outcomes

Study Arms (2)

Outpatients with a transcervical Foley catheter

EXPERIMENTAL

Women with a transcervical Foley catheter in place that will spend the night at home.

Behavioral: Outpatient

Inpatients with a transcervical Foley catheter

ACTIVE COMPARATOR

Women to be admitted to the hospital overnight which has been a "standard of care".

Behavioral: Inpatient

Interventions

OutpatientBEHAVIORAL

The offered (studied) intervention will be allowing the women with a transcervical Foley catheter in place to spend the night at home.

Outpatients with a transcervical Foley catheter
InpatientBEHAVIORAL

Women with a transcervical Foley catheter to be admitted to the hospital overnight which has been a "standard of care".

Inpatients with a transcervical Foley catheter

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women of diverse ethnic and social background who are at term and have medical indications for delivery and who are recommended to undergo cervical ripening followed by induction of labor. These will be women who are generally healthy and their pregnancy has been uncomplicated.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Indication for Induction of Labor is present
  • Gestational age \> 37 completed weeks with absence of comorbidities with an optimal dating (ultrasonography was performed before 22 weeks gestation)
  • Singleton fetus in cephalic presentation confirmed with an ultrasound at the time of presentation for induction of labor
  • Cervical exam with Bishop Score \<6
  • Intact membranes
  • Normal vital signs (blood pressure \< 140/90, normal body temperature) at the time of presentation for Induction of Labor and within the last 24 hours
  • Maternal age ≥18 years of age

You may not qualify if:

  • Any contraindication for vaginal birth by institutional policy
  • Multiple gestation
  • History of cesarean delivery
  • Oligohydramnios/polyhydramnios/anhydramnios (MVP \<2cm)
  • Rupture of membranes
  • Poorly controlled diabetes (Hgb A1C\>8% and/or fingerstick glucose above target \>50% of the time in the past week)
  • Poorly controlled chronic hypertension, gestational hypertension or preeclampsia (patient requiring IV antihypertensives within 4 hours of arrival)
  • Vaginal bleeding
  • Any conditions that require continuous electronic fetal monitoring either by institutional policy or provider determination (intrahepatic cholestasis of pregnancy, intrauterine growth restriction, abnormal non-stress test, others)
  • Fetal anomaly with anticipated neonatal intensive care unit admission
  • Fetal demise
  • HIV infection, presence of genital herpetic lesion
  • History of substance abuse during this pregnancy
  • History of precipitous delivery (delivery \<3hrs from onset of labor)
  • Poor access to care (social, distance to hospital \> 45 min, limited transportation)
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Yale New Haven Hospital- St. Raphael

New Haven, Connecticut, 06511, United States

Location

Yale New Haven Hospital, York Street Campus

New Haven, Connecticut, 06520, United States

Location

Related Publications (1)

  • Alfirevic Z, Gyte GM, Nogueira Pileggi V, Plachcinski R, Osoti AO, Finucane EM. Home versus inpatient induction of labour for improving birth outcomes. Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD007372. doi: 10.1002/14651858.CD007372.pub4.

MeSH Terms

Interventions

Inosine Monophosphate

Intervention Hierarchy (Ancestors)

Inosine NucleotidesPurine NucleotidesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsNucleotidesNucleic Acids, Nucleotides, and NucleosidesRibonucleotides

Study Officials

  • Katherine Kohari, MD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
randomized double blinded
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: two cohort double blinded clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2018

First Posted

October 31, 2018

Study Start

January 8, 2019

Primary Completion

June 27, 2022

Study Completion

June 27, 2022

Last Updated

February 22, 2023

Record last verified: 2023-02

Locations